BioCentury
ARTICLE | Clinical News

Xpert Xpress Flu/RSV regulatory update

February 16, 2017 8:27 PM UTC

FDA approved the Xpert Xpress Flu/RSV from Danaher’s Cepheid subsidiary to diagnose influenza A and B infections and respiratory syncytial virus (RSV) infection. Xpert Xpress Flu/RSV is a qualitative ...

BCIQ Company Profiles

Danaher Corp.